Welcome to our dedicated page for XELAW news (Ticker: XELAW), a resource for investors and traders seeking the latest updates and insights on XELAW stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect XELAW's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of XELAW's position in the market.
Exela Technologies announced an expanded strategic partnership valued at approximately $8 million to enhance its technology and operations solutions within the healthcare sector. This partnership is part of Exela's Healthcare Solutions business, which generated $218 million in revenue in 2021. The deployment of Exela’s PCH Global Cloud Platform aims to enhance consumer engagement and care coordination across various healthcare organizations.
Exela Technologies, Inc. (NASDAQ: XELA, XELAP) has secured a $12 million contract over three years with a leading communications firm in Europe, enhancing its communication services platform. This partnership addresses rising customer demands as Exela aims to facilitate digital transformations. The contract is part of Exela’s ITPS segment, which generated over $874 million in revenue in 2021. Exela has already commenced service delivery, marking a significant step in its growth strategy in the European market.
Exela Technologies (NASDAQ: XELA, XELAP) announced a quarterly dividend of $0.375 per share on its 6.00% Series B Cumulative Perpetual Convertible Preferred Stock. This payment will be made in cash on September 30, 2022, to stockholders of record as of September 20, 2022. With over 17,000 employees and a client base of more than 4,000 across 50 countries, Exela continues to leverage its digital transformation solutions in various industries, including finance and healthcare.
Exela Technologies, Inc. (NASDAQ: XELA, XELAP) announced a partnership with ClearBank to provide connectivity to Pay.UK's interbank Image Clearing System (ICS) using Exela's XBP™ platform. This collaboration will enhance ClearBank's capabilities in cheque processing, allowing it to extend agency banking services to multiple financial institutions. Exela's ITPS line generated $874.2 million in revenue in FY 2021, with XBP being the primary revenue driver. ClearBank's CEO expressed optimism about the partnership's potential for innovation and user experience enhancement.
Exela Technologies has announced the potential formation of a stand-alone publicly listed EMEA business valued at $220 million. This entity will operate independently and generate approximately $200 million in annual revenue. The transaction is subject to a definitive agreement and regulatory approvals, with no guarantee of completion. The capital raised is intended to support growth and corporate purposes for the new entity on Nasdaq, following Exela's previous announcement regarding asset sales exceeding $200 million.
Exela Technologies (NASDAQ: XELA, XELAP) announced a new 3-year framework contract with a public IT service provider, valued at approximately $11 million. This agreement allows Exela to implement its Digital Mail Room (DMR) module within its XBP™ Global platform across several German federal states and tax administrations. The initiative aligns with Exela's ongoing strategy to enhance its services in the German market, as highlighted by President Vitalie Robu's comments on the potential for growth and security in their offerings.
Exela Technologies has announced a share buyback program for up to 10 million shares of its common stock, authorized by the Board of Directors on August 10, 2022. This program aims to enhance shareholder value and will allow purchases through various methods including open market transactions and block trades. The buyback is not obligatory and may be altered or terminated by the Board at any time, with a duration of 24 months. The decision to repurchase shares will depend on market conditions and other investment considerations.
Exela Technologies reported Q2 2022 revenue of $266.8 million, marking a 9% decline year-over-year. The company experienced a net loss of $79.2 million, significantly higher than $19.4 million in Q2 2021. Despite these setbacks, Exela secured $230 million in Total Contract Value (TCV), a 294% increase from Q1 2022, and saw remarkable growth in its SMB segment with a 343% rise in Digital Mailroom customers. The company improved liquidity with $72 million and reduced total debt by $118 million compared to Q1 2022.
Exela Technologies, Inc. (NASDAQ:XELA) will host a conference call to discuss its second quarter 2022 results on August 9, 2022, at 4:30 p.m. ET. The call will feature Executive Chairman Par Chadha and CFO Shrikant Sortur, who will review the financial outcomes followed by a Q&A session. A press release with the results will precede the call. Investors can access the live webcast on Exela’s Investor Relations website and find details for call-in participation. A replay will be available shortly after the call until August 16, 2022.
Exela Technologies has updated its Capital Deployment Strategy, establishing XCV-STS, LLC to manage assets aimed at enhancing shareholder value. The company purchased $70 million in 2026 Senior Secured Notes at a discount using equity-raise funds, marking the first asset to STS. Interest from these notes and proceeds from planned asset sales will be utilized to return value to shareholders. While Exela is optimistic about executing the strategy, it acknowledges potential uncertainties regarding necessary approvals and successful implementations.
FAQ